SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies
- 10 May 2021
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 27 (5), 759-761
- https://doi.org/10.1038/s41591-021-01347-0
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7Nature, 2021
- Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodiesNature Medicine, 2021
- Extremely potent human monoclonal antibodies from COVID-19 convalescent patientsCell, 2021
- Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited seraNature Medicine, 2021
- Herd immunity by infection is not an optionScience, 2021
- Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited seraBiorxiv, 2021
- SARS-CoV-2 escapein vitrofrom a highly neutralizing COVID-19 convalescent plasmaPublished by Cold Spring Harbor Laboratory ,2020
- Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution SerologyCell, 2020
- Structural basis of a shared antibody response to SARS-CoV-2Science, 2020